Gilead Sciences, Inc. is a large biopharmaceutical company based in California. It lobbies Congress and federal agencies on health issues such as improving patient access to advanced immunology therapies and on policies affecting pricing, coverage, and access to biopharma products in Medicare. Filings show four disclosures totaling about $360,000, most recently in January 2026, and the firm hired Forbes-Tate to lobby for these topics.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
BARRETT THORNHILL
The latest disclosures for this client.
FORBES-TATE
Q4FORBES-TATE
Q3The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
FORBES-TATE
CYNTHIA BROWN
FORBES-TATE
DERRICK M WHITE
FORBES-TATE
ELIZABETH GREER
FORBES-TATE
KRISTINA DUNKLIN
FORBES-TATE
mr MICHAEL ALEXANDER WILLIAMS
FORBES-TATE
ANDRES RAMIREZ
FORBES-TATE
JEFFREY FORBES
FORBES-TATE
FORBES-TATE
Q2FORBES-TATE
Q1